Startups
MicroSintesis wants to change the way the world fights diseases.
Our vision is a world having more creative and effective options to fight diseases and their consequences. To do so, we need to look elsewhere. There is a growing body of evidence that supports micro-organisms having the ability to communicate with one another. Quorum sensing is the source of microbiome's balance and helps avoid dysbiosis leading to diseases or infections.
MicroSintesis wants to revolutionize human and animal welfare through harnessing microbiome's full potential.
Amongst immediate challenges, we find antibiotic resistance. This has become an increasing threat to life. While the emergence of new resistant pathogens is accelerating, the ones already there are strengthening. Medical professionalss want to reduce the use of antibiotics, but evidently will not settle for less effectiveness. MicroSintesis is not just another probiotic company. We go a step ahead, strive for discovery and strongly believe that providing health practitioners with a response to antimicrobial resistance should find its way through science.
Our solutions leverage years of worldwide scientific discoveries. We believe that our unique patented metabolite is at the heart of microbiome's communication system.
MicroSintesis pioneers the creation of a new generation of science-based microbiome and health technologies. We are committed to lead microbiome's research, discover proven & effective alternative to antibiotics, impact long standing health challenges, improve human and animal welfare and promote access to new and effective health solutions.
Our vision is a world having more creative and effective options to fight diseases and their consequences. To do so, we need to look elsewhere. There is a growing body of evidence that supports micro-organisms having the ability to communicate with one another. Quorum sensing is the source of microbiome's balance and helps avoid dysbiosis leading to diseases or infections.
MicroSintesis wants to revolutionize human and animal welfare through harnessing microbiome's full potential.
Amongst immediate challenges, we find antibiotic resistance. This has become an increasing threat to life. While the emergence of new resistant pathogens is accelerating, the ones already there are strengthening. Medical professionalss want to reduce the use of antibiotics, but evidently will not settle for less effectiveness. MicroSintesis is not just another probiotic company. We go a step ahead, strive for discovery and strongly believe that providing health practitioners with a response to antimicrobial resistance should find its way through science.
Our solutions leverage years of worldwide scientific discoveries. We believe that our unique patented metabolite is at the heart of microbiome's communication system.
MicroSintesis pioneers the creation of a new generation of science-based microbiome and health technologies. We are committed to lead microbiome's research, discover proven & effective alternative to antibiotics, impact long standing health challenges, improve human and animal welfare and promote access to new and effective health solutions.
Overview
Location
Canada, Prince Edward Island, Charlottetown
Employees
11-50
Total raised
$16.4M
Founded date
2011
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 1
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
Reviews 0
FAQ about MicroSintesis Inc.
When was MicroSintesis Inc. founded?
MicroSintesis Inc. was founded in 2011.
How much funding has MicroSintesis Inc. raised?
MicroSintesis Inc. has raised $16.4M in total across 1 funding round.
Is MicroSintesis Inc. still active?
Yes, MicroSintesis Inc. is active; its latest activity on Parsers VC dates from Jun 26, 2019.